Boston GranuFlo Recall Lawsuits Filed for Heart Attacks - Attorneys Handling Boston GranuFlo Lawsuits Offer No-Cost, No-Obligation GranuFlo Case Review
![GranuFlo Health Problems](../img/granuflo-health-problems.jpg)
Naturalyte GranuFlo Acid Concentrate and Liquid Acid Concentrate are the subjects of Boston GranuFlo recall lawsuits based on reports that the products greatly increase a patient’s risk for heart attack. Products of the German company Fresenius Medical Care, Naturalyte GranuFlo and Liquid Acid Concentrates fall into the class of dialysates and are used in dialysis treatment to cleanse the blood in conjunction with a dialysis machine. Fresenius Medical Care is the subject of an FDA investigation due to the company’s failure to warn the public of the GranuFlo heart attack risk when it was discovered in 2011. GranuFlo, which was designed to neutralize blood acidity, has a tendency to increase bicarbonate levels to a hazardous degree, making patients six times more likely to experience heart attack. GranuFlo was used in both Fresenius dialysis clinics and other clinics. Fresenius Medical Care is the nation's leading provider of dialysis clinics, machines and other dialysis products.
This website offers comprehensive information about GranuFlo heart attack risks and Boston GranuFlo lawsuits, including why GranuFlo is used in dialysis, what causes GranuFlo to be dangerous, where to find information about the GranuFlo FDA recall, what you might expect from a GranuFlo heart attack lawsuit, and how to contact a Boston GranuFlo attorney.
![GranuFlo Heart Attack](../img/granuflo_health_risks_sm.jpg)
GranuFlo Heart Attack Risk - Information for Boston Residents
GranuFlo FDA Recall - Information for Boston Residents
![GranuFlo FDA Warning](../img/granuflo_fda_warning_hm.jpg)
The FDA issued a GranuFlo Heart Attack Warning on May 25, 2012, which was followed by a Class 1 FDA GranuFlo Recall on June 27, 2012. Based on data collected at Fresenius Medical Care dialysis clinics in 2010, the FDA GranuFlo Recall warns that GranuFlo “may cause serious adverse health consequences, including death.” Class 1 recalls are the FDA's most severe level of medical recall and are used to warn medical professionals and the public of serious dangers associated with drugs. The FDA is now conducting further research to determine the full extent of GranuFlo’s dangers. Read here to learn what the GranuFlo FDA warning says, why the FDA is conducting more research and who is affected by the risk of GranuFlo heart attacks.
![Boston GranuFlo Lawsuits](../img/granuflo_lawsuits.jpg)
Boston GranuFlo Recall Lawsuits
Boston GranuFlo lawsuits may be filed by or on behalf of persons who have had a heart attack immediately after GranuFlo was used in their dialysis treatment. Fresenius Medical Care is under FDA investigation for neglecting to disclose information regarding the risk of GranuFlo heart attack, specifically that the company found that elevated levels of bicarbonate from taking GranuFlo increased a patient's risk of heart attack six-fold. Failure to disclose this information publicly may constitute a violation of federal drug safety regulations. Our Boston GranuFlo lawsuit information page will answer many of your questions as well as provide a no-cost, no-obligation Boston GranuFlo lawsuit case review.
![Boston GranuFlo Lawsuit FAQs](../img/granuflo-heart-attack-lawyers-hm.jpg)